AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
1.470
0.00 (0.00%)
At close: Sep 17, 2025
AccuStem Sciences Employees
AccuStem Sciences had 2 employees as of December 31, 2024. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$771,043
Market Cap
23.63M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | -1 | -25.00% |
| Dec 31, 2022 | 4 | 0 | - |
| Dec 31, 2021 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
AccuStem Sciences News
- 1 day ago - AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning - GlobeNewsWire
- 2 days ago - AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th - GlobeNewsWire
- 3 months ago - AccuStem Sciences, Inc. Announces Chairman Purchase of Shares - GlobeNewsWire
- 3 months ago - AccuStem Sciences, Inc. Announces Chairman Purchase of Shares - GlobeNewsWire
- 5 months ago - AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening - GlobeNewsWire
- 5 months ago - AccuStem Sciences, Inc. Announces Chairman Purchase of Shares - GlobeNewsWire
- 5 months ago - AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan - GlobeNewsWire
- 5 months ago - AccuStem Sciences, Inc. Announces Chairman Purchase of Shares - GlobeNewsWire